Clinical Trial Update: Niraparib and Temozolomide in Patients Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

Early-phase clinical trial evaluating the combination of niraparib and temozolomide in patients with glioblastoma; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temodar (Temozolomide)
• Zejula (Niraparib)

Snippet

Sponsor: Armando Santoro, MD | Conditions: Glioma, Malignant | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING